Glimepiride
Rank #382 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$25.3M
Total Cost
1,885,737
Total Claims
$25.3M
Total Cost
41,640
Prescribers
$13
Cost per Claim
401,115
Beneficiaries
4,599,705
30-Day Fills
$606
Avg Cost/Provider
45
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$25.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $25.3M total
🔎 Data Overview
At $13.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Glimepiride
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Michael Lin | Endocrinology | San Gabriel, CA | 1,303 | $29K |
| 2 | Hasan Qutob | Endocrinology | Jackson, MI | 1,115 | $26K |
| 3 | Carlos Martinez Rivera | Endocrinology | Mayaguez, PR | 994 | $25K |
| 4 | Denise Caro | Endocrinology | Mayaguez, PR | 1,026 | $19K |
| 5 | Michael Mellman | Endocrinology | Boynton Beach, FL | 1,184 | $19K |
| 6 | Carlos Muniz Molinero | Internal Medicine | Aguada, PR | 1,753 | $17K |
| 7 | Mohamed Zeitoun | Endocrinology | Hobart, IN | 847 | $15K |
| 8 | Wayne Woo | Endocrinology | Flowood, MS | 1,113 | $14K |
| 9 | Ralph Teague | Endocrinology | Birmingham, AL | 596 | $14K |
| 10 | Najmuddin Karimjee | Internal Medicine | Houston, TX | 1,000 | $13K |
| 11 | Margaret Ciechanowska | Endocrinology | Jersey City, NJ | 441 | $13K |
| 12 | Mohammad Chaudhry | Internal Medicine | Union City, NJ | 618 | $13K |
| 13 | Timothy Simon | Family Practice | Monticello, AR | 1,174 | $13K |
| 14 | Grant Sievertsen | Internal Medicine | Hinsdale, IL | 453 | $12K |
| 15 | Roberto Ortiz | Internal Medicine | Providence, RI | 693 | $12K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 379 | Citalopram Hydrobromide (Citalopram Hbr) | $25.3M | 2,778,255 |
| 380 | Amoxicillin/Potassium Clav (Amoxicillin-Clavulanate Potass) | $25.3M | 2,207,997 |
| 381 | Infliximab (Remicade) | $25.3M | 3,457 |
| 382 | Glimepiride (Glimepiride) | $25.3M | 1,885,737 |
| 383 | Flecainide Acetate (Flecainide Acetate) | $25.1M | 412,334 |
| 384 | Pioglitazone Hcl (Pioglitazone Hcl) | $24.8M | 1,182,614 |
| 385 | Fremanezumab-Vfrm (Ajovy Autoinjector) | $24.7M | 29,389 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology